- Home
- IFBD vs APRE Comparison
IFBD vs APRE Comparison
Compare IFBD & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFBD
- APRE
- Stock Information
- Founded
- IFBD 2001
- APRE 2006
- Country
- IFBD China
- APRE United States
- Employees
- IFBD N/A
- APRE N/A
- Industry
- IFBD Computer Software: Prepackaged Software
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IFBD Technology
- APRE Health Care
- Exchange
- IFBD Nasdaq
- APRE Nasdaq
- Market Cap
- IFBD 8.4M
- APRE 10.0M
- IPO Year
- IFBD 2021
- APRE 2019
- Fundamental
- Price
- IFBD $1.05
- APRE $1.71
- Analyst Decision
- IFBD
- APRE Strong Buy
- Analyst Count
- IFBD 0
- APRE 2
- Target Price
- IFBD N/A
- APRE $15.50
- AVG Volume (30 Days)
- IFBD 23.4K
- APRE 50.9K
- Earning Date
- IFBD 01-01-0001
- APRE 08-11-2025
- Dividend Yield
- IFBD N/A
- APRE N/A
- EPS Growth
- IFBD N/A
- APRE N/A
- EPS
- IFBD N/A
- APRE N/A
- Revenue
- IFBD $1,437,848.00
- APRE $1,284,475.00
- Revenue This Year
- IFBD N/A
- APRE N/A
- Revenue Next Year
- IFBD N/A
- APRE N/A
- P/E Ratio
- IFBD N/A
- APRE N/A
- Revenue Growth
- IFBD 413.52
- APRE 33.27
- 52 Week Low
- IFBD $0.89
- APRE $1.41
- 52 Week High
- IFBD $3.54
- APRE $5.01
- Technical
- Relative Strength Index (RSI)
- IFBD 50.08
- APRE 52.34
- Support Level
- IFBD $1.00
- APRE $1.48
- Resistance Level
- IFBD $1.06
- APRE $1.91
- Average True Range (ATR)
- IFBD 0.05
- APRE 0.16
- MACD
- IFBD 0.01
- APRE -0.00
- Stochastic Oscillator
- IFBD 35.71
- APRE 63.14
About IFBD Infobird Co. Ltd
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.